Kyle Moran
Officer, Wave Life Sciences.
Companies
- Wave Life SciencesChief financial officer Dec 11, 2020 to now1
- Wave Life SciencesOfficer Nov 10, 2015 to Jun 17, 20162
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Wave Life Sciences WVE134,385 shares3$427.3K at $3.18Feb 9, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 9, 2026Sold 3,588 shares at $13.45 of Wave Life Sciences3
- Feb 5, 2026Granted 45,625 shares of Wave Life Sciences3
- Dec 9, 2025Sold 50,000 shares at $20.03 of Wave Life Sciences4
- Dec 9, 2025Exercised options 50,000 shares at $10.48 of Wave Life Sciences4
- Dec 9, 2025Sold 36 shares at $20.25 of Wave Life Sciences4
- Dec 9, 2025Exercised options 36,000 shares at $8.17 of Wave Life Sciences4
- Dec 8, 2025Sold 50,000 shares at $18.00 of Wave Life Sciences4
- Dec 8, 2025Exercised options 50,000 shares at $4.75 of Wave Life Sciences4
- Dec 8, 2025Sold 50,000 shares at $13.20 of Wave Life Sciences4
- Dec 8, 2025Sold 50,000 shares at $15.00 of Wave Life Sciences4
- Dec 8, 2025Exercised options 100,000 shares at $3.14 of Wave Life Sciences4
- Dec 8, 2025Sold 60,000 shares at $13.20 of Wave Life Sciences4
- Dec 8, 2025Exercised options 60,000 shares at $2.83 of Wave Life Sciences4
- Feb 4, 2025Granted 42,000 shares of Wave Life Sciences5
- Oct 11, 2024Exercised options 25,000 shares at $2.48 of Wave Life Sciences6
- Sep 25, 2024Sold 17,146 shares at $9.00 of Wave Life Sciences7
- Apr 3, 2024Sold 15,630 shares at $6.17 of Wave Life Sciences8
- Aug 23, 2023Sold 37,062 shares at $4.75 of Wave Life Sciences9
- Feb 16, 2023Sold 9,729 shares at $4.04 of Wave Life Sciences10
- May 5, 2022Sold 5,021 shares at $1.72 of Wave Life Sciences11
- May 4, 2022Granted 15,000 shares of Wave Life Sciences11
- Feb 16, 2022Sold 9,204 shares at $2.31 of Wave Life Sciences12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARWave Life Sciences, Officer
- 3
- 4SEC EDGARForm 4 filed Dec 10, 2025
- 5SEC EDGARForm 4 filed Feb 6, 2025
- 6SEC EDGARForm 4 filed Oct 11, 2024
- 7SEC EDGARForm 4 filed Sep 27, 2024
- 8SEC EDGARForm 4 filed Apr 5, 2024
- 9SEC EDGARForm 4 filed Aug 23, 2023
- 10SEC EDGARForm 4 filed Feb 17, 2023
- 11SEC EDGARForm 4 filed May 6, 2022
- 12SEC EDGARForm 4 filed Feb 18, 2022